Amgen's Financial Surge: Beating Expectations and Raising Projections

Amgen's Financial Surge: Beating Expectations and Raising Projections

Amgen's Financial Surge: Beating Expectations and Raising Projections Amgen exceeded Wall Street expectations with its quarterly financial report and adjusted its year-end outlook upwards. The California biotech firm achieved a 12% increase in sales, surpassing expenses associated with experimental drugs and a higher tax rate.Key revenue drivers included a 40% sales increase for cholesterol-lowering drug Repatha. Conversely, sales for the arthri…